openPR Logo
Press release

Global Diabetes Care Devices Market to Surge to USD 117.7 Billion by 2034, Driven by Technological Innovations and Rising Diabetes Prevalence | FMI

05-08-2025 08:10 AM CET | Health & Medicine

Press release from: Future Market Insights Inc

Diabetes Care Devices Market

Diabetes Care Devices Market

The global diabetes care devices market is poised for substantial expansion, with projections indicating a rise from USD 64.5 billion in 2024 to an impressive USD 117.7 billion by 2034. The market's growth is fueled by the increasing prevalence of diabetes worldwide, advancements in diabetes management technology, and lifestyle-related factors contributing to higher incidence rates of the disease.

Market Growth Fueled by Rising Diabetes Cases and Technological Innovations

According to industry analysts, the diabetes care devices market is set to grow at a compound annual growth rate (CAGR) of 6.2% between 2024 and 2034. The demand for diabetes management solutions continues to surge due to an increase in diabetes cases globally, rapid urbanization, and the adoption of sedentary lifestyles, which elevate the risk of diabetes-related complications.

Explore Emerging Market Insights: Request a Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-236

As millions of individuals worldwide grapple with diabetes, the need for effective, user-friendly, and technologically advanced solutions has never been more critical. The diabetes care devices industry is undergoing a transformation, with continuous innovations enhancing patient monitoring, treatment, and overall disease management.

Technological Advancements Transforming Diabetes Care

Breakthroughs in medical technology are playing a pivotal role in reshaping diabetes management, offering patients greater convenience and accuracy in monitoring their condition. Some of the most notable advancements driving market expansion include:

• Next-Generation Blood Glucose Monitoring Systems: The adoption of continuous glucose monitoring (CGM) devices and non-invasive glucose monitoring technologies is revolutionizing diabetes care. These innovations provide real-time insights into blood sugar levels, reducing the need for frequent finger-prick tests and enhancing patient adherence.

• Smart Insulin Delivery Systems: The increasing use of smart insulin pens and insulin pumps is improving diabetes management by enabling precise, automated insulin delivery. These devices optimize insulin dosing, reduce human error, and enhance patient compliance.

• AI and Digital Health Integration: Artificial intelligence (AI) and digital health technologies are ushering in a new era of personalized diabetes care. AI-driven predictive analytics, combined with remote patient monitoring, is allowing for early intervention and improved disease management.

Rising Diabetes Prevalence and Lifestyle Changes Fueling Market Expansion

The rising global burden of diabetes remains a primary driver of market growth. As urbanization accelerates and lifestyle patterns shift toward unhealthy diets and reduced physical activity, more individuals are developing diabetes. According to the International Diabetes Federation (IDF), diabetes prevalence is expected to rise significantly in the coming decades, further intensifying the need for innovative diabetes care solutions.

Governments, healthcare organizations, and advocacy groups worldwide are actively promoting early diagnosis and proactive diabetes management, contributing to increased awareness and adoption of diabetes care devices. The emphasis on preventive healthcare strategies and lifestyle modifications is further supporting the market's expansion.

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends! https://www.futuremarketinsights.com/reports/diabetes-care-devices-market

Key Takeaways

• The global Diabetes Care Devices Market is estimated to reach USD 64.5 billion in 2024 and is projected to grow to USD 117.7 billion by 2034, reflecting a CAGR of 6.2% from 2024 to 2034.

• Regional growth highlights include:

o India is expected to see the highest growth with an 8.8% CAGR between 2024 and 2034.

o China follows closely with an 8.4% CAGR during the same period.

o South Korea anticipates a 8.1% CAGR.

o Australia is projected to grow at a 6.7% CAGR.

o France is expected to grow at a 4.3% CAGR.

o The United States is forecast to record a 3.4% CAGR.

This growth trajectory reflects strong market potential, with significant regional variations in market dynamics.

Opportunities for Manufacturers and Healthcare Providers

With the rising demand for diabetes care solutions, the market presents significant growth opportunities for medical device manufacturers, healthcare providers, and technology companies. Investment in research and development (R&D) is expected to accelerate, leading to the introduction of more efficient, cost-effective, and patient-centric diabetes management tools.

Key areas of opportunity include

• AI-Powered and Automated Diabetes Care Devices: The integration of AI into diabetes management is enabling smarter, data-driven decision-making for patients and healthcare providers. AI-powered devices can predict blood sugar fluctuations, personalize treatment plans, and enhance patient outcomes.

• Expansion of Telemedicine and Remote Patient Monitoring Solutions: With the increasing adoption of telehealth, virtual diabetes management platforms are gaining momentum. Remote patient monitoring solutions allow real-time tracking of blood glucose levels, ensuring timely intervention and reducing hospital visits.

• Enhanced Accessibility and Affordability of Diabetes Management Tools: Efforts to make diabetes care devices more affordable and accessible are essential for market growth. Governments and healthcare organizations are working to expand insurance coverage and reimbursement policies, improving access to essential diabetes management solutions.

• Collaborations Between Healthcare Providers and Tech Companies: Partnerships between medical device manufacturers, pharmaceutical companies, and technology firms are driving innovation in diabetes care. By leveraging expertise from multiple sectors, companies can develop advanced solutions that enhance patient experience and treatment effectiveness.

Competition Outlook

The diabetes management tools market is moderately fragmented, with a mix of prominent players and emerging startups. Leading manufacturers focus on strengthening their market presence through new product launches, acquisitions, and technological advancements. However, competition remains fierce as startups introduce innovative solutions at competitive prices.

To boost their success, many startups adopt strategies such as product development, market expansion, mergers and acquisitions, and strategic partnerships. These efforts contribute to the overall growth of the diabetes care devices market by fostering increased innovation.

Industry Updates

• In August 2024, Medtronic formed a strategic partnership with Abbott to enhance its diabetes care segment. This collaboration aims to integrate advanced glucose monitoring technology, strengthening Medtronic's product offerings and potentially improving its position in the market.

• In October 2024, Glooko secured a USD 100 million investment to expand its diabetes management system. The funding is intended to support the company's growth in North America, the Middle East, and Asia.

Leading Diabetes Care Devices Brands

• Abbott Laboratories
• ACON Laboratories, Inc.
• Ascensia Diabetes Care Holdings AG
• Becton
• Dickinson and Company
• Dexcom, Inc.
• F. Hoffmann-La Roche Ltd
• Johnson & Johnson
• Medtronic plc
• Novo Nordisk A/S
• Terumo Corporation

Discover the Latest Healthcare Trends Today! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device

Key Segments of Market Report

By Product Type:
The diabetes care devices market includes glucose monitoring devices, insulin delivery devices, artificial pancreas, and diabetes management mobile applications. Glucose monitoring devices include continuous monitoring devices, lancets, test strips, and self-monitoring devices. Insulin delivery devices include insulin pumps, pens, and syringes and needles.

By Indication:
The segment is classified into diabetes type I, diabetes type II, and gestational diabetes.

By End User:
The market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and diabetes clinics or stores.

By Region:
Information about the leading countries of North America, Latin America, Western Europe, South Asia and Pacific, East Asia, and the Middle East and Africa is given.

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Diabetes Care Devices Market to Surge to USD 117.7 Billion by 2034, Driven by Technological Innovations and Rising Diabetes Prevalence | FMI here

News-ID: 4004786 • Views:

More Releases from Future Market Insights Inc

Endoscopy Fluid Management Systems Market Poised for Significant Growth, Projected to Surpass USD 1.1 Billion by 2035 Key Players Hologic Inc, B. Braun Medical Inc., Medtronics Plc., Cantel Medical Corporation and Others
Endoscopy Fluid Management Systems Market Poised for Significant Growth, Project …
The global Endoscopy Fluid Management Systems Market is on a trajectory of significant expansion, with a new market forecast projecting its value to more than double over the next decade. According to the latest analysis, the market, valued at an estimated USD 550.3 million in 2025, is expected to surge to USD 1,123.7 million by 2035. This robust growth represents a compound annual growth rate (CAGR) of 7.4% and is
NGS Sample Preparation Market Poised for Explosive Growth, Set to Triple by 2035 Key Players Macrogen, Inc., Eurofins Scientific, Illumina, Inc., F Hoffman-La Roche AG and Others
NGS Sample Preparation Market Poised for Explosive Growth, Set to Triple by 2035 …
A new market analysis projects the global Next-Generation Sequencing (NGS) Sample Preparation market to experience a significant surge, forecasting a valuation of USD 7.0 billion by 2035. This marks a substantial increase from its estimated USD 1.9 billion value in 2025, reflecting a robust Compound Annual Growth Rate (CAGR) of 13.7% over the decade. The findings underscore the pivotal role of sample preparation in the expanding field of genomics, driven
Eye and Face Protection Market USD 2.3 Billion by 2035 Key Players Medline Industries, Cardinal Health Inc., DMC Medical Ltd., Lifelong Meditech (Group) and Others
Eye and Face Protection Market USD 2.3 Billion by 2035 Key Players Medline Indus …
The global Eye and Face Protection Market is poised for significant expansion, with a new forecast predicting it will grow from an estimated USD 859.3 million in 2025 to USD 2,332.2 million by 2035. This robust growth trajectory represents a compound annual growth rate (CAGR) of 10.5% over the forecast period, driven by a confluence of rising industrial safety awareness, stringent regulatory mandates, and technological innovation. Click Here for More Information:-
Dermatology Excimer Lasers Market to Nearly Triple by 2035 Key Players Cutera, Inc., The Daavlin Company, Shenzhen GSD Tech Co., Ltd., DEKA Research & Development Corp and Others
Dermatology Excimer Lasers Market to Nearly Triple by 2035 Key Players Cutera, I …
The global market for dermatology excimer lasers is projected to surge from an estimated USD 109.7 million in 2025 to a remarkable USD 317.1 million by 2035, marking a significant compound annual growth rate (CAGR) of 11.2%. This substantial expansion is being fueled by a combination of factors, including the rising global prevalence of chronic skin conditions and a growing preference for advanced, targeted therapies. Click Here for More Information:- https://www.futuremarketinsights.com/reports/dermatology-excimer-lasers-market Dermatology

All 5 Releases


More Releases for Diabetes

Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size? The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools. The diabetes pen market is projected to grow strongly, reaching $40.17 billion
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28). According to Type-2 Diabetes Market
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end